Seroepidemiology and High Negativity of IgG Antibodies Against Human Papillomavirus (HPV) Type 6, 11, 16, and 18 Virus-like Particles in Women of Childbearing Age in Port Harcourt, Nigeria

REFERENCES

• Denny, L. Human Papillomavirus Infections: Epidemiology, Clinical Aspects and Vaccines. Open Infect. Dis. J. 2009, 3, 135–142.
   Google Scholar
• Adegbesan-Omilabu, M.A.; Okunade, K.S.; Omilabu, S.A. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014, 2(2), 625–630.
   Google Scholar
• Aral, S.O.; Holmes, K.K. The Epidemiology of STIs and Their Social and Behavioural Determinants: Industrialized and Developing Countries. In Sexually Transmitted Diseases. 4th ed.; Holmes, K.K., Sparling, P.F., Stamm, W.E., Piot, P., Wasserheit, J.N., Corey, L., Cohen, M.S., Watts, D.H., Eds.; McGraw-Hill: New York, 2008; pp 53–92.
   Google Scholar
• Ogoina, D.; Musa, B.O.; Onyemelukwe, G.C. Human Papilloma Virus (HPV) Infection is Associated with HIV-1 Infection and AIDS in HIV-Infected Adult Patients from Zaria, Northern Nigeria. Pan Afr. Med. J. 2013, 15, 38.
   PubMedGoogle Scholar
• Nouvo, G.J.; Darfler, M.M.; Impraim, C.C.; Bromley, S.E. Occurrence of Multiple Types of Human Papillomavirus in Genital Tract Lesions: Analysis by in situ Hybridisation and the Polymerase Chain Reaction. Amer. J. Pathol. 1999, 138, 53–58.
   Google Scholar
• World Health Organization (WHO). Human Papillomavirus and HPV Vaccines: Technical Information for Policy-Makers and Health Professionals. WHO Press: Geneva, 2007.
   Google Scholar
• Adekunle, A.; Sule, W.F.; Oluwayelu, D.O. High Negativity of IgG Antibodies against Human Papillomavirus Type 6, 11, 16 and 18 Virus-Like Particles in Healthy Women of Childbearing Age. J. Expe. Integr. Med. 2014, 4(1), 37–41.
   Google Scholar
• Lowy, D.R.; Schiller, J.T. Prophylactic Human Papillomavirus Vaccines. J. Clin. Invest. 2006, 116, 1167–73.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortality & Morbidity Weekly Report (MMWR) 2007, 56, RR-2.
   Google Scholar
• Carter, J.J.; Koutsky, L.A.; Hughes, J.P.; Lee, S.K.; Kuypers, J.; Kiviat, N.; Galloway, D.A. Comparison of Human Papillomavirus Type 16, 18, and 6 Capsid Antibody Responses Following Incident Infection. J. Infect. Dis. 2000, 181, 1911–1919.
   PubMed Web of Science ®Google Scholar
• Scheurer, M.E.; Tortolero-Luna, G.; Adler-Storthz, K. Human Papillomavirus Infection: Biology, Epidemiology, and Prevention. Int. J. Gynaecol. Obstet. 2005, 15, 727–746.
   Google Scholar
• Pagliusi, S.R.; Dillner, J.; Pawlita, M.; Quint, W.G.V.; Wheeler, C.M.; Ferguson, M. International Standard Reagents for Harmonization of HPV Serology and DNA Assays—An Update. Vaccine 2006, 24, S193–S200.
   Web of Science ®Google Scholar
• Newall, A.T.; Brotherton, J.M.; Quinn, H.E.; McIntyre, P.B.; Backhouse, J.; Gilbert, L.; Esser, M.T.; Erick, J.; Bryan, J.; Formica, N.; MacIntyre, C.R. Population Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia. Clin. Infect. Dis. 2008, 46, 1647–1655.
   PubMed Web of Science ®Google Scholar
• Skjeldestad, F.E.; Mehta, V.; Sings, H.L.; Ovreness, T.; Turpin, J.; Su, L.; Boerckel, P.; Roberts, C.; Bryan, J.; Jansen, K.U.; Esser, M.T.; Liaw, K.L. Seroprevalence and Genital DNA Prevalence of HPV Types 6, 11, 16 and 18 in a Cohort of Young Norwegian Women: Study Design and Cohort Characteristics. Acta. Obstet. Gynecol. Scand. 2008, 87, 81–88.
   PubMed Web of Science ®Google Scholar
• Rama, C.H.; Roteli-Martins, C.M.; Derchain, S.F.; Oliveira, E.Z.; Aldrighi, J.M.; Mariani, N.C. Serological Detection of Anti HPV 16/18 and its Association with Pap Smear in Adolescents and young women. Rev. Assoc. Med. Bras. 2006, 52, 43–47.
   PubMedGoogle Scholar
• Viscidi, R.P.; Schiffman, M.; Hildesheim, A.; Herrero, R.; Castle, P.E.; Bratti, M.C.; Rodriguez, A.C.; Sherman, M.E.; Wang, S.; Clayman, B.; Burk, R.D. Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica. Cancer Epidemiol. Biomark. Prev. 2004, 13, 324–327.
   PubMed Web of Science ®Google Scholar
• Clifford, G.M.; Shin, H.R.; Oh, J.K.; Waterboer, T.; Ju, Y.H.; Vaccarella, S.; Quint, W.; Pawlita, M.; Franceschi, S. Serologic Response to Oncogenic Human Papillomavirus Types in Male and Female University Students in Busan, South Korea. Cancer Epidemiol. Biomark. Prev. 2007, 16, 1874–1879.
   PubMed Web of Science ®Google Scholar
• Wang, I.J.; Viscidi, R.; Hwang, K.C.; Lin, T.Y.; Chen, C.J.; Huang, L.M.; Chen, H.H.; Chen, C.J. Seroprevalence and Risk Factors for Human Papillomavirus in Taiwan. J. Trop. Pediatr. 2008, 54, 14–18.
   PubMed Web of Science ®Google Scholar
• Newton, R.; Bousarghin, L.; Ziegler, J.; Casabonne, D.; Beral, V.; Mbidde, E.; Carpenter, L.; Parkin, D.M.; Wabinga, H.; Mbulaiteye, S.; Jaffe, H.; Touze, A.; Coursaget, P.; The Uganda Kaposi’s Sarcoma Study Group. Uganda Kaposi’s Sarcoma Study Group. Human Papillomaviruses and Cancer in Uganda. Eur. J. Cancer Prev. 2004, 13, 113–118.
   PubMed Web of Science ®Google Scholar
• Franceschi, S.; Herrero, R.; Clifford, G.M.; Snijders, P.J.; Arslan, A.; Anh, P.T.; Bosch, F.X.; Ferreccio, C.; Hieu, N.T.; Lazcano-Ponce, E.; Matos, E.; Molano, M.; Qiao, Y.L.; Rajkumar, R.; Ronco, G.; de Sanjosé, S.; Shin, H.R.; Sukvirach, S.; Thomas, J.O.; Meijer, C.J.; Muñoz, N. Variations in the Age-Specific Curves of Human Papillomavirus Prevalence in Women Worldwide. Int. J. Cancer. 2006, 119, 2677–2684.
   PubMed Web of Science ®Google Scholar
• Njoku, O.N. Eastern Nigeria Under British Rule. Department of History, University of Nigeria (University of Nigeria, Nsukka); 2008, p 23.
   Google Scholar
• Mbakwem-Aniebo, C.; Ezekoye, C.C.; Okonko, I.O. Detection of HIV-1 and -2 antibodies among Freshmen of the University of Port Harcourt, Port Harcourt, Southern Nigeria. World Appl. Sci. J. 16(8), 2012, 1087–1092.
   Google Scholar
• Mbakwem-Aniebo, C.; Ezekoye, C.C.; Okonko, I.O. Knowledge about HIV/AIDS, and Reported Risk Behaviours among Freshmen of the University of Port Harcourt, Port Harcourt, Southern Nigeria. World Appl. Sci. J. 2012, 16(8), 1093–1103.
   Google Scholar
• National Population Commission (NPC). Census of the Federal Republic of Nigeria. Abuja, 2006.
   Google Scholar
• Thomas, J.O.; Herrero, R.; Omigbodun, A.A.; Ojemakinde, K.; Ajayi, I.O.; Fawole, A.; Oladepo, O.; Smith, J.S.; Arslan, A.; Mun˜oz. N.; Snijders, P.J.F.; Meijer, C.J.L.M.; Franceschi, S. Prevalence of Papillomavirus Infection in Women in Ibadan, Nigeria: A Population-Based Study. Brit. J. Cancer 2004, 90, 638–645.
   PubMed Web of Science ®Google Scholar
• Okolo, C.; Franceschi, S.; Adewole, I.; Thomas, J.O.; Follen, M.; Snijders, P.J.; Meijer, C.J.; Clifford, G.M. Human Papillomavirus Infection in Women with and without Cervical Cancer in Ibadan, Nigeria. Infect. Agent Cancer 2010, 5, 24.
   PubMedGoogle Scholar
• Vaccarella, S.; Franceschi, S.; Clifford, G.M.; Touze, A.; Hsu, C.C.; de Sanjose, S.; Anh, P.T.H.; Hieu, N.T.; Matos, E.; Shin, H.R.; Sukvirach, S.; Thomas, J.O.; Boursaghin, L.; Gaitan, J.; Snijders, P.J.F.; Meijer, C.J.L.M.; Muñoz, N.; Herrero, R.; Coursaget, P; for the IARC HPV Prevalence Surveys Study Group. Seroprevalence of Antibodies against Puman Papillomavirus (HPV) Types 16 and 18 in Four Continents: The International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol. Biomark. Prev. 2010, 19, 2379–2388.
   PubMed Web of Science ®Google Scholar
• Gage, J.C.; Ajenifuja, K.O.; Wentzensen, N.A.; Adepiti, A.C.; Eklund, C.; Reilly, M.; Hutchinson, M.; Wacholder, S.; Harford, J.; Soliman, A.S.; Burk. R.D.; Schiffman, M. The Age-Specific Prevalence of Human Papillomavirus and Risk of Cytologic Abnormalities in Rural Nigeria: Implications for Screen-and-Treat Strategies. Int. J. Cancer 2012, 130, 2111–2117.
   PubMed Web of Science ®Google Scholar
• Serwadda, D.; Wawer, M.J.; Shah, K.V.; Sewankambo, N.K.; Daniel, R.; Li, C.; Lorincz, A.; Meehan, M.P.; Wabwire-Mangen, F.; Gray, R.H. Use of a Hybrid Capture Assay of Self-Collected Vaginal Swabs in Rural Uganda for Detection of Human Papillomavirus. J. Infect. Dis. 1999, 180, 1316–1319.
   PubMed Web of Science ®Google Scholar
• Womack, S.D.; Chirenje, Z.M.; Gaffikin, L.; Blumenthal, P.D.; McGrath, J.A.; Chipato, T.; Ngwalle, S.; Munjoma, M.; Shah, K.V. HPV-Based Cervical Cancer Screening in a Population at High Risk for HIV Infection. Int. J. Cancer 2000, 85, 206–210.
   PubMed Web of Science ®Google Scholar
• Castellsague, X.; Menendez, C.; Loscertales, M.P.; Kornegay, J.R.; dos Santos, F.; Gomez-Olive, F.X.; Lloveras, B.; Abarca, N.; Vaz, N.; Barreto, A.; Bosch, F.X.; Alonso, P. Human Papillomavirus Genotypes in Rural Mozambique. Lancet 2001, 358, 1429–1430.
   PubMed Web of Science ®Google Scholar
• Gravitt, P.E.; Kamath, A.M.; Gaffikin, L.; Chirenje, Z.M.; Womack, S.; Shah, K.V. Human Papillomavirus Genotype Prevalence in High-Grade Squamous Intraepithelial Lesions and Colposcopically Normal Women from Zimbabwe. Int. J. Cancer 2002, 100, 729–732.
   PubMed Web of Science ®Google Scholar
• Xi, L.F.; Toure, P.; Critchlow, C.W.; Hawes, S.E.; Dembele, B.; Sow, P.S.; Kiviat, N.B. Prevalence of Specific Types of Human Papillomavirus and Cervical Squamous Intraepithelial Lesions in Consecutive, Previously Unscreened, West-African Women over 35 Years of Age. Int. J. Cancer 2003, 103, 803–809.
   PubMed Web of Science ®Google Scholar
• De Vuyst, H.; Steyaert, S.; Van Renterghem, L.; Claeys, P.; Muchiri, L.; Sitati, S.; Vansteelandt, S.; Quint, W.; Kleter, B.; Van Marck, E.; Temmerman, M. Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya. Sex. Transm. Dis. 2003, 30, 137–142.
   PubMed Web of Science ®Google Scholar
• Burk, R.D.; Kelly, P.; Feldman, J.; Bromberg, J.; Vermund, S.H.; DeHovitz, J.A.; Landesman, S.H. Declining Prevalence of Cervicovaginal Human Papillomavirus Infection with Age is Independent of Other Risk Factors. Sex Transmitt. Dis. 1996, 23, 333–341.
   PubMed Web of Science ®Google Scholar
• Adam, E.; Berkova, Z.; Daxnerova, Z.; Icenogle, J.; Reeves, W.C.; Kaufman, R.H. Papillomavirus Detection: Demographic and Behavioral Characteristics Influencing the Identification of Cervical Disease. Amer. J. Obstet. Gynecol. 2000, 182, 257–264.
   PubMed Web of Science ®Google Scholar
• Burd, E.M. Human Papillomavirus and Cervical Cancer. Clin. Microbiol. Rev. 2003, 16, 1–17.
   PubMed Web of Science ®Google Scholar
• Amosu, A.M.; Degun, A.M.; Babalola, A.O.; Thomas, M.A. Level of Specific Knowledge, Awareness, Perception, and Screening Behavior Regarding Carcinoma of the Cervix among Rural Women in Iwo Local Government Area, Osun State, Nigeria. Ann. Biol. Res. 2011, 2, 206–221.
   Google Scholar
• World Health Organization (WHO). Human Papillomavirus and HPV Vaccines: Technical Information for Policy-Makers and Health Professionals. WHO Press: Geneva, 2007.
   Google Scholar
• Touze, A.; De Sanjose, S.; Coursaget, P.; Almirall, M.R.; Palacio, V.; Meijer, C.J.L.M.; Kornegay, J.; Bosch, F.X. Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes. J. Clin. Microbiol. 2001, 39, 4344–4348.
   PubMed Web of Science ®Google Scholar